Jacob Hallesy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacob Hallesy has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Amit Sharma
Virginia Commonwealth University Health System
4 shared publicationsMuhammad Saeed
Virginia Commonwealth University Health System
4 shared publications- Seung Duk Lee
Department of Surgery Division of Transplant Surgery Hume‐ Lee Transplant Center Virginia Commonwealth University School of Medicine Richmond Virginia USA
4 shared publications Adrian Cotterell
Department of Transplant Surgery, Virginia Commonwealth University Medical Center (Hume-Lee Transplant Center), VCU Medical Center Gateway Building, Richmond, USA
3 shared publicationsDaisuke Imai
Virginia Commonwealth University Health System
3 shared publicationsVinay Kumaran
Virginia Commonwealth University Health System
3 shared publications
Latest Publications
- 28 October 2026
- Published by SAGE Publications in The American Surgeon™
Robotic Living Donor Hepatectomy After Previous Abdominal Surgery: Feasibility in a Carefully Selected Cohort
Background: Previous abdominal surgery (PAS) complicates open and laparoscopic living donor hepatectomy through intra-abdominal adhesions. Whether a robotic-intended strategy is feasible in donors with prior operations has not been described. A single-center experience in carefully selected donors is described. Methods: All living donor hepatectomies at a single US center (August 2019 to December 2024) were reviewed. The primary intention-to-treat cohort comprised all 31 robotic-intended cases (13 PAS, 18 No-PAS), and the 28 cases intended for fully robotic completion served as a sensitivity analysis. PAS was classified as upper or lower abdominal. Exploratory comparisons appear as effect estimates with 95% confidence intervals. Results: Robotic-intended hepatectomy was completed in all 13 PAS donors, 5 with prior upper abdominal surgery. Neither bile leak nor liver failure developed in a PAS donor, and adhesions accounted for no conversion. Blood loss, operative time, and hospital stay did not differ significantly, yet the confidence intervals stayed wide (hospital stay difference 1 day (95% CI −0.5 to 3)), so similarity cannot be established. Ileus affected 6 of 13 PAS donors and clustered in the upper abdominal subgroup, 4 of 5 (80.0%; 95% CI 28.4 to 99.5%); across all 12 events, 11 were Clavien-Dindo grade I. Discussion: At an experienced center, a robotic-intended strategy proved feasible across varied previous operations. The donors described here were selected, so safety or equivalence cannot be established. Lower abdominal PAS may be managed routinely, whereas upper abdominal PAS calls for selective use in experienced programs together with prospective study.
- 28 October 2026
- Published by SAGE Publications in The American Surgeon™
Robotic Living Donor Hepatectomy After Previous Abdominal Surgery: Feasibility in a Carefully Selected Cohort
Background: Previous abdominal surgery (PAS) complicates open and laparoscopic living donor hepatectomy through intra-abdominal adhesions. Whether a robotic-intended strategy is feasible in donors with prior operations has not been described. A single-center experience in carefully selected donors is described. Methods: All living donor hepatectomies at a single US center (August 2019 to December 2024) were reviewed. The primary intention-to-treat cohort comprised all 31 robotic-intended cases (13 PAS, 18 No-PAS), and the 28 cases intended for fully robotic completion served as a sensitivity analysis. PAS was classified as upper or lower abdominal. Exploratory comparisons appear as effect estimates with 95% confidence intervals. Results: Robotic-intended hepatectomy was completed in all 13 PAS donors, 5 with prior upper abdominal surgery. Neither bile leak nor liver failure developed in a PAS donor, and adhesions accounted for no conversion. Blood loss, operative time, and hospital stay did not differ significantly, yet the confidence intervals stayed wide (hospital stay difference 1 day (95% CI −0.5 to 3)), so similarity cannot be established. Ileus affected 6 of 13 PAS donors and clustered in the upper abdominal subgroup, 4 of 5 (80.0%; 95% CI 28.4 to 99.5%); across all 12 events, 11 were Clavien-Dindo grade I. Discussion: At an experienced center, a robotic-intended strategy proved feasible across varied previous operations. The donors described here were selected, so safety or equivalence cannot be established. Lower abdominal PAS may be managed routinely, whereas upper abdominal PAS calls for selective use in experienced programs together with prospective study.
- Open Access
- 8 September 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-11
Expanding the living kidney donor pool: outcomes of robotic donor nephrectomy in obese versus non-obese donors
Background: Robotic donor nephrectomy (RDN) offers a minimally invasive alternative to open and laparoscopic techniques for living kidney donation. As obesity rises among potential donors, data comparing RDN outcomes between non-obese and obese donors remain limited. This study evaluates the safety and feasibility of RDN in obese living kidney donors. Methods: A single-center retrospective analysis included 212 consecutive donors who underwent RDN between August 2020 and April 2025; after excluding one donor with incomplete covariate data, 211 (137 low BMI [< 30 kg/m 2 ], 74 high BMI [≥ 30 kg/m 2 ]) formed the analytic cohort. To account for baseline imbalance, the primary between-group comparison used propensity-score overlap weighting, with weighted differences and 95% confidence intervals (CIs) estimated by robust weighted regression. Results: Low BMI donors were modestly older (46.2 vs. 42.2 years; largest imbalance, standardized mean difference 0.32); overlap weighting reduced all covariate differences to approximately zero. After weighting, operating time was longer in high BMI donors (weighted difference + 15.6 min, 95% CI 6.4–24.8; p < 0.001), whereas estimated blood loss, conversion to open surgery (1.4% vs. 0.7%), complications (2.7% vs. 2.2%; all Clavien–Dindo Grade I), length of stay, and renal function through six months did not differ (all weighted p > 0.10). No perioperative deaths occurred. Exploratory subgroup analyses showed longer operating times for high BMI donors with single renal arteries ( p = 0.011) and left nephrectomies ( p = 0.024), without differences in blood loss or complications. Conclusion: In a rigorously selected cohort, RDN yielded short-term perioperative and functional outcomes in obese donors comparable to non-obese donors, with only a modest increase in operative time that persisted after overlap weighting. These findings support RDN as one component of responsibly expanding the donor pool; however, short-term parity does not establish long-term donor or recipient safety, and expansion must remain contingent on stringent selection, risk counseling, and structured long-term surveillance.
- 8 September 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-11
Open AccessExpanding the living kidney donor pool: outcomes of robotic donor nephrectomy in obese versus non-obese donors
Background: Robotic donor nephrectomy (RDN) offers a minimally invasive alternative to open and laparoscopic techniques for living kidney donation. As obesity rises among potential donors, data comparing RDN outcomes between non-obese and obese donors remain limited. This study evaluates the safety and feasibility of RDN in obese living kidney donors. Methods: A single-center retrospective analysis included 212 consecutive donors who underwent RDN between August 2020 and April 2025; after excluding one donor with incomplete covariate data, 211 (137 low BMI [< 30 kg/m 2 ], 74 high BMI [≥ 30 kg/m 2 ]) formed the analytic cohort. To account for baseline imbalance, the primary between-group comparison used propensity-score overlap weighting, with weighted differences and 95% confidence intervals (CIs) estimated by robust weighted regression. Results: Low BMI donors were modestly older (46.2 vs. 42.2 years; largest imbalance, standardized mean difference 0.32); overlap weighting reduced all covariate differences to approximately zero. After weighting, operating time was longer in high BMI donors (weighted difference + 15.6 min, 95% CI 6.4–24.8; p < 0.001), whereas estimated blood loss, conversion to open surgery (1.4% vs. 0.7%), complications (2.7% vs. 2.2%; all Clavien–Dindo Grade I), length of stay, and renal function through six months did not differ (all weighted p > 0.10). No perioperative deaths occurred. Exploratory subgroup analyses showed longer operating times for high BMI donors with single renal arteries ( p = 0.011) and left nephrectomies ( p = 0.024), without differences in blood loss or complications. Conclusion: In a rigorously selected cohort, RDN yielded short-term perioperative and functional outcomes in obese donors comparable to non-obese donors, with only a modest increase in operative time that persisted after overlap weighting. These findings support RDN as one component of responsibly expanding the donor pool; however, short-term parity does not establish long-term donor or recipient safety, and expansion must remain contingent on stringent selection, risk counseling, and structured long-term surveillance.
- 14 April 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (7) , 1076-1079
Normothermic liver machine perfusion would help not only clinical outcomes but also surgical team sustainability
- 14 April 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (7) , 1076-1079
Normothermic liver machine perfusion would help not only clinical outcomes but also surgical team sustainability
- Open Access
- 30 January 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (2) , e70463
Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation
Normothermic regional perfusion (NRP) has emerged as a pivotal strategy in controlled donation after circulatory death (cDCD) liver transplantation, mitigating ischemia‐reperfusion injury and improving graft outcomes. Compared to super rapid recovery (SRR), NRP significantly reduces rates of early allograft dysfunction, primary nonfunction, and biliary non‐anastomotic stricture (NAS), with biliary complications reported in 5%–16% and NAS as low as 0%–2%. Outcomes from cDCD‐NRP grafts are increasingly comparable to those of donation after brain death (DBD). Viability assessment during NRP remains variably defined across centers. Nonetheless, stable pump flow, stable or declining lactate levels, controlled transaminase levels, and favorable macroscopic appearance are commonly used parameters. Histological thresholds may guide graft acceptance but are not universally applied. Sequential use of ex situ machine perfusion following NRP offers additional benefits in marginal or prolonged ischemia settings. NRP implementation has improved liver utilization rates from 34% to 63% in the United Kingdom and from 39% to 71% in the United States. This review highlights NRP as a transformative platform that reshapes viability standards, expanding transplant access, and supports sustained growth in liver transplantation.
- 30 January 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (2) , e70463
Open AccessNormothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation
Normothermic regional perfusion (NRP) has emerged as a pivotal strategy in controlled donation after circulatory death (cDCD) liver transplantation, mitigating ischemia‐reperfusion injury and improving graft outcomes. Compared to super rapid recovery (SRR), NRP significantly reduces rates of early allograft dysfunction, primary nonfunction, and biliary non‐anastomotic stricture (NAS), with biliary complications reported in 5%–16% and NAS as low as 0%–2%. Outcomes from cDCD‐NRP grafts are increasingly comparable to those of donation after brain death (DBD). Viability assessment during NRP remains variably defined across centers. Nonetheless, stable pump flow, stable or declining lactate levels, controlled transaminase levels, and favorable macroscopic appearance are commonly used parameters. Histological thresholds may guide graft acceptance but are not universally applied. Sequential use of ex situ machine perfusion following NRP offers additional benefits in marginal or prolonged ischemia settings. NRP implementation has improved liver utilization rates from 34% to 63% in the United Kingdom and from 39% to 71% in the United States. This review highlights NRP as a transformative platform that reshapes viability standards, expanding transplant access, and supports sustained growth in liver transplantation.